- Home
- CNEY vs XXII Comparison
CNEY vs XXII Comparison
Compare CNEY & XXII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNEY
- XXII
- Stock Information
- Founded
- CNEY 2018
- XXII 1998
- Country
- CNEY China
- XXII United States
- Employees
- CNEY N/A
- XXII N/A
- Industry
- CNEY Major Chemicals
- XXII Medicinal Chemicals and Botanical Products
- Sector
- CNEY Industrials
- XXII Health Care
- Exchange
- CNEY Nasdaq
- XXII Nasdaq
- Market Cap
- CNEY 2.1M
- XXII 2.1M
- IPO Year
- CNEY 2021
- XXII N/A
- Fundamental
- Price
- CNEY $0.12
- XXII $1.08
- Analyst Decision
- CNEY
- XXII
- Analyst Count
- CNEY 0
- XXII 0
- Target Price
- CNEY N/A
- XXII N/A
- AVG Volume (30 Days)
- CNEY 36.0M
- XXII 603.9K
- Earning Date
- CNEY 01-01-0001
- XXII 05-13-2025
- Dividend Yield
- CNEY N/A
- XXII N/A
- EPS Growth
- CNEY N/A
- XXII N/A
- EPS
- CNEY N/A
- XXII N/A
- Revenue
- CNEY $50,957,974.00
- XXII $23,869,000.00
- Revenue This Year
- CNEY N/A
- XXII $19.23
- Revenue Next Year
- CNEY N/A
- XXII $81.05
- P/E Ratio
- CNEY N/A
- XXII N/A
- Revenue Growth
- CNEY N/A
- XXII N/A
- 52 Week Low
- CNEY $0.11
- XXII $0.70
- 52 Week High
- CNEY $1.60
- XXII $226.80
- Technical
- Relative Strength Index (RSI)
- CNEY 37.87
- XXII 47.15
- Support Level
- CNEY $0.16
- XXII $1.06
- Resistance Level
- CNEY $0.29
- XXII $1.26
- Average True Range (ATR)
- CNEY 0.04
- XXII 0.17
- MACD
- CNEY -0.00
- XXII 0.04
- Stochastic Oscillator
- CNEY 0.56
- XXII 49.25
About CNEY CN Energy Group Inc.
CN Energy Group Inc along with its subsidiaries is a manufacturer and supplier of wood-based activated carbon that is used in pharmaceutical manufacturing, industrial manufacturing, water purification, environmental protection, and food and beverage production and a producer of biomass electricity generated in the process of producing activated carbon. The firm generates a majority of its revenue from Activated carbon.
About XXII 22nd Century Group Inc.
22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.